University of Oxford spin-out secures $55m Series C to fight undiagnosed heart failure
Ultromics, an Oxford-based pioneer in AI-driven cardiology solutions, has raised $55 million in Series C financing. The round was co-led by L&G, Allegis Capital and Lightrock, with continued support from Oxford Science Enterprises, GV, Blue Venture Fund and Oxford University, the company’s alma mater.